Clinical and laboratory findings
| Patient No | Occlusion type | Age (years)/sex | ET-1 levels (pg/ml) | Systemic hypertension (+/−) | Ocular hypertension (+/−) |
|---|---|---|---|---|---|
| Group A, RVO patients (n = 18): | 14.22 (4.6) | ||||
| Group A1: NIT RVO (n = 11) | 12.46 (4.3) | ||||
| 1 | BRVO | 57/M | 5.6 | − | + |
| 2 | BRVO | 64/F | 10.3 | + | − |
| 3 | BRVO | 65/M | 18.3 | − | + |
| 4 | BRVO | 66/F | 8.7 | + | − |
| 5 | BRVO | 66/M | 12.6 | − | − |
| 6 | BRVO | 73/M | 13.5 | − | − |
| 7 | CRVO | 41/M | 9.0 | − | − |
| 8 | CRVO | 52/M | 14.1 | − | + |
| 9 | CRVO | 63/F | 14.4 | + | − |
| 10 | CRVO | 72/F | 10.2 | + | + |
| 11 | CRVO | 74/F | 20.4 | + | + |
| Group A2: IT RVO (n = 7) | 16.97 (3.5) | ||||
| 12 | BRVO | 62/M | 18.4 | + | − |
| 13 | BRVO | 67/M | 13.7 | − | −() |
| 14 | BRVO | 68/M | 14.2 | + | −() |
| 15 | CRVO | 54/F | 18.3 | + | + |
| 16 | CRVO | 58/M | 16.2 | + | − |
| 17 | CRVO | 68/M | 24.2 | + | + |
| 18 | CRVO | 70/F | 13.8 | + | − |
| Group B, Normal subjects (n=20) | 7.90 (1.6) | ||||
| Group C, Uncomplicated hypertensives (n=15) | 8.50 (2.9) | ||||
NIT RVO = non-ischaemic type retinal vein occlusions; IT RVO = ischaemic type retinal vein occlusions; BRVO = branch retinal vein occlusions; CRVO = central retinal vein occlusions.
↵Mean (SD).
↵p Value <0.05 for group A and A1 v groups B and C, respectively, and for group A2 v group A1.
↵p Value <0.01 for group A2 v groups B and C, respectively.
↵Patients with neovascular glaucoma at the time of diagnosis and blood sampling.
↵Bilateral anterior chamber angle narrowing upon examination.
↵History of borderline intraocular pressure (range 18–20 mm Hg).